| 000 | 01701 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517202859.0 | ||
| 264 | 0 | _c20180305 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1536-5964 | ||
| 024 | 7 |
_a10.1097/MD.0000000000009513 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, Chin-Chuan | |
| 245 | 0 | 0 |
_aPrognostic significance of retention index of bone marrow on dual-phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-cell lymphoma. _h[electronic resource] |
| 260 |
_bMedicine _cJan 2018 |
||
| 300 |
_ae9513 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Marrow _xdiagnostic imaging |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPositron Emission Tomography Computed Tomography |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCho, Shih-Feng | |
| 700 | 1 | _aChuang, Ya-Wen | |
| 700 | 1 | _aLin, Chia-Yang | |
| 700 | 1 | _aHuang, Ying-Fong | |
| 700 | 1 | _aTyan, Yu-Chang | |
| 773 | 0 |
_tMedicine _gvol. 97 _gno. 2 _gp. e9513 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000009513 _zAvailable from publisher's website |
| 999 |
_c28122519 _d28122519 |
||